Share this article on:

Long-Term Efficacy of Adalimumab for Treatment of Moderately to Severely Active Ulcerative Colitis: P-19

Colombel, Jean-Frédéric1; Sandborn, William2; Wolf, Doug3; Panaccione, Remo4; Lazar, Andreas5; Kron, Martina5; Robinson, Anne6; Thakkar, Roopal6

Abstracts from the 2012 Advances in Inflammatory Bowel Diseases Crohn's & Colitis Foundation's National Clinical & Research Conference December 13–15, 2012 Hollywood, Florida: Clinical Poster Presentations